The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...
This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...
Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million- driven by growth in MIPLYFFA net revenue to $87.4 million 2025 EPS of $1.40 basic ...
Objective Autoimmune rheumatic diseases, including rheumatoid arthritis (RA), have recently been associated with an increased risk of cancer, particularly head and neck cancer (HNC). This study aimed ...
When Chadwick Boseman died in August 2020 at the age of 43, the world learned that the beloved star of Black Panther had ...
Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.
John (Eddie) La Marca receives funding from Cancer Council Victoria. He is affiliated with the Olivia Newton-John Cancer Research Institute and the Walter and Eliza Hall Institute of Medical Research.
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
WashU researchers have created a model that can seemingly predict a person's symptoms of Alzheimer's within a few years. Reading time 3 minutes Sickness and death are inevitable, but many of us will ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results